The relationship of obesity with the severity of psoriasis: A systematic review

Journal of Cutaneous Medicine and Surgery

Volumn 19, Issue 5, 2015, Pages 450-456

  Fleming, Patrick ^a   Kraft, John ^b   Gulliver, Wayne P ^c   Lynde, Charles ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b Lynde Dermatology   (Canada)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Obesity; Psoriasis

Indexed keywords

AGE; BODY MASS; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; MULTIVARIATE ANALYSIS; OBESITY; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; REVIEW; SEX; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; COMPLICATION;

HUMANS; OBESITY; PSORIASIS;

EID: 84946104415     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/1203475415586332     Document Type: Review

References (31)

1. Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis, section 1: overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58(5):826-850.
2. Gulliver W. Long-term prognosis in patients with psoriasis. Br J Dermatol. 2008;159(suppl 2):2-9.
3. Mussi A, Bonifati C, Carducci M, et al. Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis. J Biol Regul Homeost Agents. 1997;11(3):115-118.
4. Calder PC, Ahluwalia N, Brouns F, et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr. 2011;106(suppl 3):S5-S78.
5. O'Rourke RW. Inflammation, obesity, and the promise of immunotherapy for metabolic disease. Surg Obes Relat Dis. 2013;9(5):609-616.
6. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
7. US Preventive Services Task Force. U.S. Preventive Services Task Force procedure manual. Appendix VII. AHRQ Publication No. 08-05118-EF. July 2008. http://www.ncbi. nlm.nih.gov/books/NBK47515/. Accessed February 25, 2013. 2008.
8. Howick J, Chalmers I, Glasziou P, et al. Oxford levels of evidence 2. Oxford Centre for Evidence-Based Medicine. http:// www.cebm.net/index.aspx?o=5653. Accessed March 1, 2013.
9. Ahdout J, Kotlerman J, Elashoff D, Kim J, Chiu MW. Modifiable lifestyle factors associated with metabolic syndrome in patients with psoriasis. Clin Exp Dermatol. 2012;37(5):477-483.
10. Bhole VM, Choi HK, Burns LC, et al. Differences in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology (Oxford). 2012;51(3): 552-556.
11. Bardazzi F, Balestri R, Baldi E, Antonucci A, De Tommaso S, Patrizi A. Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy. Dermatol Ther. 2010;23(suppl 1):S14, S19.
12. Huang YH, Yang LC, Hui RY, et al. Relationships between obesity and the clinical severity of psoriasis in Taiwan. J Eur Acad Dermatol Venereol. 2010;24(9):1035-1039.
13. Murray ML, Bergstresser PR, Adams-Huet B, Cohen JB. Relationship of psoriasis severity to obesity using samegender siblings as controls for obesity. Clin Exp Dermatol. 2009;34(2):140-144.
14. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55(5):829-835.
15. Soltani-Arabshahi R, Wong B, Feng BJ, Goldgar DE, Duffin KC, Krueger GG. Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol. 2010;146(7):721-726.
16. Duarte GV, Oliveira Mde F, Cardoso TM, et al. Association between obesity measured by different parameters and severity of psoriasis. Int J Dermatol. 2013;52(2):177-181.
17. Xue K, Liu H, Jian Q, et al. Leptin induces secretion of proinflammatory cytokines by human keratinocytes in vitro-a possible reason for increased severity of psoriasis in patients with a high body mass index. Exp Dermatol. 2013;22(6):406-410.
18. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr. 2006;83(2):461S-465S.
19. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999;19(4):972-978.
20. Zahorska-Markiewicz B, Olszanecka-Glinianowicz M, Janowska J, Kocelak P. The effect of weight loss on serum concentrations of FAS and tumour necrosis factor alpha in obese women. Endokrynol Pol. 2008;59(1):18-22.
21. Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm. 2005;2005(5):273-279.
22. Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6(6):383-392.
23. Block JP, He Y, Zaslavsky AM, Ding L, Ayanian JZ. Psychosocial stress and change in weight among US adults. Am J Epidemiol. 2009;170(2):181-192.
24. Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet. 2005;6(3):221-234.
25. Jensen P, Zachariae C, Christensen R, et al. Effect of weight loss on the severity of psoriasis: a randomized clinical study. JAMA Dermatol. 2013;149(7):795-801.
26. de Menezes Ettinger JE, Azaro E, de Souza CA, et al. Remission of psoriasis after open gastric bypass. Obes Surg. 2006;16(1):94-97.
27. Farias MM, Achurra P, Boza C, Vega A, de la Cruz C. Psoriasis following bariatric surgery: clinical evolution and impact on quality of life on 10 patients. Obes Surg. 2012;22(6):877-880.
28. Hossler EW, Maroon MS, Mowad CM. Gastric bypass surgery improves psoriasis. J Am Acad Dermatol. 2011;65(1): 198-200.
29. Hamminga EA, van der Lely AJ, Neumann HA, Thio HB. Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses. 2006;67(4):768-773.
30. Papp K, Poulin Y, Vieira A. Examining the risk of cardiovascular disease in patients with psoriasis: a critical review. J Cutan Med Surg. 2013;17(2):89-105.
31. Fleming P, Godwin M. Lifestyle interventions in primary care: systematic review of randomized controlled trials. Can Fam Physician. 2008;54(12):1706-1713.